Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KKT-ASTRO: Kamikihito for Anxiety and Social Communication in Adults with Autism Spectrum Disorder
jRCTs051250184Recruiting
- Sponsor
- Tsumura & Co.
- Start
- May 2026
- Countries
- 1
01
Overview
Open-label, single-arm trial of kamikihito in Autism Spectrum Disorder (ASD), anxiety disorder and Social Anxiety Disorder (SAD), sponsored by Tsumura & Co. Primary endpoint: Change from baseline in STAI-T score at 12 weeks. Started May 2026; status: recruiting.
02
Drugs
kamikihito
03
Conditions
Autism Spectrum Disorder (ASD)anxiety disorderSocial Anxiety Disorder (SAD)
Beyond the preview
Go deeper on jRCTs051250184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051250184.